Jeffrey M. Testani

Nov 1, 2024 | jacc.org | Mikhail Kosiborod |David Cherney |Akshay S. Desai |Jeffrey M. Testani

AbstractBackgroundMineralocorticoid receptor antagonists (MRA) improve outcomes in patients with heart failure and reduced ejection fraction (HFrEF) but are underused in clinical practice. Observational data suggest that hyperkalemia is the leading obstacle for the suboptimal use of MRA. ObjectivesWe evaluated the effects of sodium zirconium cyclosilicate (SZC) in optimizing use of spironolactone among participants with HFrEF and hyperkalemia.

Mar 11, 2024 | onlinelibrary.wiley.com | Zachary Cox |Jeffrey M. Testani

Invited Editorial The salt paradox in heart failure Zachary L. Cox,  Zachary L. Cox Department of Pharmacy Practice, Lipscomb University College of Pharmacy, Nashville, TN, USA Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USASearch for more papers by this authorJeffrey M. Testani,  Corresponding Author Jeffrey M.

Jul 24, 2023 | ahajournals.org | Milton Packer |Christopher Wilcox |Jeffrey M. Testani

Privacy Preference CenterWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device. Because we respect your right to privacy, you can choose not to allow certain types of cookies on our website. Click on the different category headings to find out more and manage your cookie preferences.

Jun 26, 2023 | pubmed.ncbi.nlm.nih.gov | Kevin Damman |Jeffrey M. Testani

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software